Kario, Kazuomi http://orcid.org/0000-0002-8251-4480
Hoshide, Satoshi
Yamamoto, Koichi
Okura, Ayako
Rakugi, Hiromi http://orcid.org/0000-0001-6508-4338
Article History
Received: 14 October 2020
Revised: 12 March 2021
Accepted: 26 March 2021
First Online: 7 May 2021
Compliance with ethical standards
:
: KK has received independent principal investigator-initiated research grants from Omron Healthcare Inc., Fukuda Denshi Inc., A&D Inc., Taisho Pharmaceutical Co. Inc., and Sanwa Kagaku Kenkyusho Co. Inc. HR and KY have received independent principal investigator-initiated research grants from Astellas Pharma Inc., Daiichi Sankyo Co., Kyowa Hakko Kirin Co., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Takeda Pharmaceutical Company and Teijin Pharma. HR has received lecture fees from Daiichi Sankyo Co. and Takeda Pharmaceutical Company. SH has received research grants from Sanofi Co., Astellas Pharma Inc. and Novartis Pharma K.K. AO has no conflicts of interest to declare.